Aantal gebruikers 2016-2020 voor ATC-subgroep A10B : Bloedglucoseverlagende middelen excl. insulines
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| A10BA Biguaniden | 635.080 | 648.470 | 651.630 | 655.050 | 645.270 |
| A10BB Sulfonylureumderivaten | 293.590 | 300.760 | 304.010 | 308.680 | 304.560 |
| A10BD Combinaties van bloedglucoseverlagende middelen | 10.799 | 10.878 | 10.951 | 11.074 | 10.532 |
| A10BF Alfa-glucosidaseremmers | 1.425 | 1.454 | 1.400 | 1.233 | 884 |
| A10BG Thiazolidinedionen | 5.634 | 4.704 | 3.871 | 3.253 | 2.622 |
| A10BH Dipeptidylpeptidase-4-remmers | 34.406 | 35.174 | 38.148 | 44.255 | 45.796 |
| A10BJ Glucagonachtig peptide-1-agonisten (glp-1-agonisten) | 11.304 | 12.925 | 15.895 | 26.280 | 38.557 |
| A10BK Natriumglucose-cotransporter-2-remmers (sglt-2-remmers) | 6.605 | 11.254 | 15.443 | 16.900 | 19.690 |
| A10BX Overige bloedglucoseverlagende middelen excl. insulines | 826 | 642 | 697 | 701 | 685 |